MedTrace Logo

Prospective Metabolic Surgery in T2DM Chinese Subjects

NCT02217943 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2025-03-30

No results posted yet for this study

Summary

The primary goal of this study is to assess impact of metabolic surgery on glycemic control in diabetic patients.

Conditions

Interventions

PROCEDURE

Roux-en-Y gastric bypass

PROCEDURE

Sleeve gastrectomy

Sponsors & Collaborators

  • Ethicon Endo-Surgery

    lead INDUSTRY

Principal Investigators

  • Robin Scamuffa · Ethicon, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2018-06-05
Completion
2021-04-11

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02217943 on ClinicalTrials.gov